Next-generation implantable defibrillators feature additional safety features to elevate the standard of care ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc. (STJ), a global medical device company, today announced CE Mar...
Devices, Cardiology, Regulatory
St. Jude Medical, implantable cardioverter defibrillator

Investigational Device Exemption (IDE) Approval to Enroll 2,051 Patients in a Randomized Controlled Trial SUNNYVALE, Calif--(Healthcare Sales & Marketing Network)--Elixir Medical Corporation, a developer of products that combine state-of-the-art medical...
Devices, Interventional Cardiology, FDA
Elixir Medical, EXCELLA III, DESyne Nx, Novolimus, drug eluting stent

Rods Are Lengthened by Remote Control, Eliminating Need for Multiple Surgeries SAN DIEGO, May 8, 2013 -- (Healthcare Sales & Marketing Network) -- In a revolutionary treatment for early-onset scoliosis (EOS), a team of surgeons implanted adjustable gro...
Devices, Orthopaedic
Ellipse Technologies, scoliosis, growing rods, MAGEC, Magnetic Expansion Control

Dose Tracking and Spot Fluoroscopy Showcased at HRS and SCAI TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--Providing clinicians real time data to optimize radiation dose management during cardiac procedures, Toshiba America Medical Systems, In...
Devices, Radiology, Interventional Cardiology
Toshiba America Medical Systems, Infinix-i, cardiovascular X-ray, Dose Tracking

WIESBADEN, Germany, May 7, 2013 -- (Healthcare Sales & Marketing Network) -- OrbusNeich Medical, Inc. and its German subsidiary, OrbusNeich Medical GmbH (collectively "OrbusNeich") announced that it has fulfilled all the requirements established...
Devices, Interventional Cardiology, Litigation
OrbusNeich Medical, Boston Scientific, cardiac stent, coronary stent

BIOTRONIK continues 50-year legacy of engineering excellence with smaller, thinner ICD/CRT-D, including the unique DX platform LAKE OSWEGO, Ore.--(Healthcare Sales & Marketing Network)--BIOTRONIK, a leading manufacturer of cardiovascular medical technol...
Devices, Cardiology, FDA
BIOTRONIK, Ilesto 7, implantable cardioverter-defibrillator, ICD, CRT-D

MONROVIA, Calif.--(Healthcare Sales & Marketing Network)--3M Unitek announced today it has successfully resolved U.S. and French patent lawsuits related to sales by RMO, Inc. (doing business as Rocky Mountain Orthodontics) of customized lingual orthodontic...
Devices, Dental, Litigation
3M, 3M Unitek, Rocky Mountain Orthodontics, Orthodontics

Point-of-care diagnostic test enables rapid detection of deadly Lassa viral hemorrhagic fever and related bioterrorism threat DENVER--(Healthcare Sales & Marketing Network)--Corgenix Medical Corporation (OTC BB: CONX), a worldwide developer and marketer...
Diagnostics, Regulatory
Corgenix Medical, ReLASV, Lassa Fever, Viral Hemorrhagic Fever

BURLINGTON, Mass., May 7, 2013 -- (Healthcare Sales & Marketing Network) -- Coronado Biosciences, Inc. (CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer...
Biopharmaceuticals, Gastroenterology, Personnel
Coronado Biosciences, inflammatory bowel disease

MIAMISBURG, Ohio--(Healthcare Sales & Marketing Network)--X-spine, a global leader in the design and manufacture of devices for the treatment of spinal disease, announces a new USFDA clearance for the Zygafix™ Facet Fusion System. The newly-cleared Zygafix...
Devices, Neurosurgery, Orthopaedic, FDA
X-spine Systems, Zygafix, Facet Fusion System, spine surgery

DEERFIELD, Ill.--(Healthcare Sales & Marketing Network)--Baxter International Inc. (BAX) today announced that its Phase III clinical study of immunoglobulin (IG) did not meet its co-primary endpoints of reducing cognitive decline and preserving functional ...
Biopharmaceuticals, Neurology
Baxter, immunoglobulin, Alzheimer’s disease

Guideline provides detailed direction on treatment options for prostate cancer patients SAN DIEGO, May 7, 2013 -- (Healthcare Sales & Marketing Network) -- The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA...
Devices, Urology, Oncology
American Urological Association, ASTRO , radiotherapy, prostate cancer

Reduces risks associated with oversedation, facilitates faster patient recovery and increases physician satisfaction CINCINNATI, May 3, 2013 -- (Healthcare Sales & Marketing Network) -- Sedasys, a Division of Ethicon Endo-Surgery, Inc. (Ethicon), today...
Devices, Drug Delivery, Gastroenterology, Oncology, FDA
Sedasys, Ethicon Endo-Surgery, Propofol, Colonoscopy

MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it will be exhibiting its Magellan™ Robotic System at the 8th Annual European Symposium of Vasc...
Devices, Interventional
Hansen Medical, Magellan Robotic System

NATICK, Mass., May 6, 2013 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) completed a first-in-human clinical trial utilizing the IntellaTip MiFi™ XP Ablation Catheter for the treatment of type 1 atrial flutter, an arrhyt...
Devices, Cardiology
Boston Scientific, IntellaTip, MiFi XP, Ablation Catheter, atrial fibrillation

BLOOMINGTON, Ind.--(Healthcare Sales & Marketing Network)--A new, cost-effective endoscopic option is now available to urologists. Physicians can use the Flexor® Vue™ Deflecting Endoscopic System during urological procedures to access and visualize bod...
Devices, Urology, Product Launch
Cook Medical, endoscopy, Flexor Vue, Deflecting Endoscopic System

Popular radiofrequency treatment provides early and, long-lasting results HAYWARD, Calif., May 6, 2013 -- (Healthcare Sales & Marketing Network) -- Solta Medical, Inc. (SLTM), the global market leader in aesthetic skin treatments, today announced the T...
Devices, Dermatology
Solta Medical, Thermage, Total Tip 3.0, aesthetic skin treatment

Financing led by RA Capital with a syndicate of healthcare specialist investors PASADENA, Calif.--(Healthcare Sales & Marketing Network)--Arrowhead Research Corporation (ARWR), a targeted therapeutics company, today announced that on May 3, 2013 it clos...
Biopharmaceuticals, Venture Capital
Arrowhead Research, hepatitis B, ARC-520

After Successful Pre-IND Meeting, Company On Track to Advance Lead Compound NPT002 into Clinical Trials for Alzheimer's Disease in 2014 Funds Will Accelerate Development of Novel 2nd Generation Fusion Proteins for Treating Neurodegenerative Disorders ...
Biopharmaceuticals, Venture Capital, Personnel
NeuroPhage Pharmaceuticals

The agreement enables Mercury to exclusively market ETView's VivaSight™ platform in several US states, including Florida, Georgia, South Carolina, North Carolina, Virginia, Maryland, District of Columbia, Tennessee, Arkansas, Alabama, Mississippi, Louisian...
Devices, Distribution
ETView Medical, Mercury Medical, VivaSight